Related Experiment Video
Updated: Jul 10, 2026
10:38
Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Clinical governance and the coroner
1Wales Institute of Forensic Medicine, Cardiff.
Journal of the Royal College of Physicians of London
|January 7, 2000
Summary
Independent scrutiny of medical deaths is needed in England and Wales. Current systems are inadequate, but coroners could be more involved with political will and resources.
Area of Science:
- Medical Law and Ethics
- Public Health Policy
- Healthcare Quality Improvement
Background:
- Public demand for high standards in medical practice and accountability.
- Current systems for scrutinizing deaths following medical treatment in England and Wales are insufficient.
- Existing financial and legislative constraints hinder best practice in medical death investigation.
Purpose of the Study:
- To advocate for a transparent, informed, and independent scrutiny system for deaths post-medical treatment.
- To assess the current framework for investigating medical-related deaths.
- To identify potential improvements within existing legal and resource structures.
Main Methods:
- Analysis of public expectations regarding medical standards and accountability.
- Evaluation of the current system of death investigation in England and Wales.
- Review of existing legal provisions for coroner involvement in medical death inquiries.
Main Results:
- The current system in England and Wales does not meet the need for transparent and independent scrutiny of medical deaths.
- Financial and legislative limitations impede optimal investigation practices.
- The law permits greater coroner involvement in investigating deaths following medical treatment.
Conclusions:
- A transparent, informed, and independent scrutiny system for medical deaths is essential for public interest.
- Enhanced coroner involvement in investigating post-medical treatment deaths is feasible under current law.
- Professional willingness for self-scrutiny and political commitment to resource allocation are crucial for implementing improvements.
Related Concept Videos
01:22Standards of Care I
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
01:19Standards of Care II
Nurses bear specific legal responsibilities under several federal statutes, including:
01:23Nurses' Legal Responsibilities II
Establishing a secure, collaborative nurse-patient relationship is crucial for delivering high-quality care. This relationship, founded on trust, respect, and honesty, enhances the patient's comfort and willingness to share vital health information. For example, a nurse who listens actively and without judgment provides clear information about health conditions and treatment options and respects patient decisions, which builds a trusting relationship.
Communication between nurses and patients...
Communication between nurses and patients...
01:16Nurses' Legal Responsibilities III
Nurse-to-nurse relationships are legally required to adhere to professional standards, ensuring a respectful and positive working environment. Professional conduct demands that nurses treat all colleagues respectfully and courteously, fostering a productive, supportive workplace. Nurses must actively eliminate bullying, discrimination, and harassment to maintain a safe and inclusive environment.
Cultivating a culture of collaboration and mutual respect among nurses transcends mere enhancement...
Cultivating a culture of collaboration and mutual respect among nurses transcends mere enhancement...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:26Principles of Disease Surveillance
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...